File size: 2,181 Bytes
6e8f1b7 |
1 |
{"0": "Metabolism of steroids", "1": "Biological oxidations", "2": "Diseases of metabolism", "3": "Glycosaminoglycan metabolism", "4": "Sphingolipid metabolism", "5": "Glycosphingolipid metabolism", "6": "Cholesterol biosynthesis", "7": "Trans golgi network vesicle budding", "8": "Iron uptake and transport", "9": "Transferrin endocytosis and recycling", "10": "Response to elevated platelet cytosolic ca2", "11": "Ion channel transport", "12": "Diseases of glycosylation", "13": "Phase i functionalization of compounds", "14": "Activation of gene expression by srebf srebp", "15": "Regulation of cholesterol biosynthesis by srebp srebf", "16": "Metabolism of vitamins and cofactors", "17": "Cyclin a cdk2 associated events at s phase entry", "18": "Cdt1 association with the cdc6 orc origin complex", "19": "Phospholipid metabolism", "20": "Rhoa gtpase cycle", "21": "Scf skp2 mediated degradation of p27 p21", "22": "Antigen processing cross presentation", "23": "Transport of vitamins nucleosides and related molecules", "24": "Metabolism of polyamines", "25": "Cellular response to hypoxia", "26": "Mitochondrial protein import", "27": "Retrograde transport at the trans golgi network", "28": "Signaling by insulin receptor", "29": "Regulation of runx3 expression and activity", "30": "Regulation of pten stability and activity", "31": "Cyclin d associated events in g1", "32": "Degradation of axin", "33": "Cross presentation of soluble exogenous antigens endosomes", "34": "Regulation of runx2 expression and activity", "35": "Phase ii conjugation of compounds", "36": "Regulation of hmox1 expression and activity", "37": "Negative regulation of notch4 signaling", "38": "Fceri mediated nf kb activation", "39": "Asymmetric localization of pcp proteins", "40": "Signaling by the b cell receptor bcr", "41": "Platelet activation signaling and aggregation", "42": "Degradation of gli1 by the proteasome", "43": "G1 s dna damage checkpoints", "44": "Defective cftr causes cystic fibrosis", "45": "Abc transporter disorders", "46": "Stabilization of p53", "47": "Tgf beta receptor signaling activates smads", "48": "Glycerophospholipid biosynthesis", "49": "Degradation of dvl"} |